Lucid Down More Than 50%? Why It Could Turn Around
Lucid has fallen sharply, dropping more than half in the last year. This article breaks down why the stock’s slump ha...
Which Travel Rewards Credit Cards Have No Fee
Discover which travel rewards credit cards come with no fees. Enjoy your travels while saving money on fees.
26,830 articles
Pi Network News Today: Mainnet Progress Sparks Uptick
Pi Network reports rising KYC completion and robust Mainnet migration, as upgrades lay groundwork for smart contracts...
Anthropic Confidentially Files After Strong Funding Round
Anthropic has confidentially filed for an IPO after closing a $65 billion funding round at a near-trillion-dollar val...
Bitcoin Steadies Near $64k: What Traders Need to Know
Bitcoin steadies near $64k as hawkish Fed rhetoric rattles markets. This guide breaks down what to watch, where a flo...
Congress Made 6,170 ‘Insider’ Trades in 16 Months, Experts
A new watchdog analysis shows lawmakers traded on information tied to pending votes, raising questions about ethics a...
Unstoppable Stock Before Joins META Could Ride to a 3T Club
META sits at a pivotal moment. With AI-enabled engagement, ad momentum, and new monetization paths, analysts wonder i...
These Altcoins Crash Hard After Binance Delisting Shake Markets
Binance announced a sweeping delisting of eight altcoins, sending prices lower and forcing traders to reassess holdin...
Ethereum News: Lee’s BitMine Slashes ETH Buying 74%
BitMine slashed its weekly Ethereum purchases by 74% to 26,659 ETH, just as it edges toward a 5% stake of circulating...
Down From Highs, This Micro-Cap Could Be Growth Stock Under $30
A little-known micro-cap trading under $30 is drawing renewed investor interest as quarterly results show improving p...
Ethereum’s Biggest Risk Funding: Looming Crunch Ahead in 2026
A looming funding crunch could threaten Ethereum’s roadmap within the next three to nine months. An ex-Ethereum Found...
Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status